CIK 0001711754 · Non-accelerated filer<br>Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 475205835
- Phone
- 8589643720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-30 | Moss David J Chief Financial Officer | Purchase | +10,000 | $5.29 | $53K | 1,285,869 |
| 2024-09-12 | Tesi Raymond Joseph President and CEO | Purchase | +15,380 | $6.38 | $98K | 1,554,106 |
| 2024-09-12 | Tesi Raymond Joseph President and CEO | Purchase · Common Stock Warrants (right to buy) | +15,380 | $0.13 | $2K | 15,380 |
| 2024-09-12 | Moss David J Chief Financial Officer | Purchase | +7,690 | $6.38 | $49K | 1,275,869 |
| 2024-09-12 | Moss David J Chief Financial Officer | Purchase · Common Stock Warrants (right to buy) | +7,690 | $0.13 | $961 | 7,690 |
| 2024-06-25 | Juda Scott Director | Purchase | +5,000 | $7.27 | $36K | 71,603 |
| 2024-06-10 | Tesi Raymond Joseph President and CEO | Grant or award · Option (right to buy) | +37,882 | 37,882 | ||
| 2024-05-14 | Tesi Raymond Joseph President and CEO | Grant or award · Option (right to buy) | +160,000 | 160,000 | ||
| 2024-05-14 | Schroeder Timothy j Director | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2024-05-14 | Moss David J Chief Financial Officer | Grant or award · Option (right to buy) | +160,000 | 160,000 | ||
| 2024-05-14 | Lowdell Mark William Chief Scientific Officer | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2024-05-14 | Juda Scott Director | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2024-05-14 | Ganjei James Kelly Director | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2024-05-14 | Baracchini Edgardo Jr Director | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2024-05-14 | ALLEN MARCIA Director | Grant or award · Option (right to buy) | +12,500 | 12,500 | ||
| 2024-04-19 | Moss David J CFO, Treasurer & Secretary | Purchase | +18,028 | $8.32 | $150K | 1,268,179 |
| 2024-04-19 | Moss David J CFO, Treasurer & Secretary | Purchase · Common Stock Warrants (right to buy) | +18,028 | $0.13 | $2K | 18,028 |
| 2024-04-19 | Tesi Raymond Joseph President and CEO | Purchase | +18,028 | $8.32 | $150K | 1,538,726 |
| 2024-04-19 | Tesi Raymond Joseph President and CEO | Purchase · Common Stock Warrants (right to buy) | +18,028 | $0.13 | $2K | 18,028 |
| 2024-04-19 | Lowdell Mark William Chief Scientific Officer | Purchase | +14,423 | $8.32 | $120K | 1,510,806 |
Page 7 of 11 · 216 trades